Protein Discovery Summit 2013 – Deciphering Protein-Protein & Protein-Drug Interactions

In 2012, there were 40 drugs approved by the FDA – 28 of them were small molecules and 12 were other biologics. Understanding protein-protein and protein-small molecule interaction is crucial to the drug discovery process. To this end, GTC is delighted to present the Protein Discovery Summit 2013 – Deciphering Protein-Protein & Protein-Drug Interactions held on October 23-25, 2013 at the Paradise Point Resort & Spa in San Diego, CA.

With over 300 anticipated attendees, the Protein Discovery Summit is the ideal venue to network with your fellow researchers. The summit provides access to over 125 presentations from leading industrial and academic experts and will feature research findings, case studies and technology advancements. The Protein Discovery Summit will cover major hot topics in the field such as antibody drug conjugates, novel antibody targets, novel design of binders, difficult to express proteins, analytic tools, protein interaction as drug targets, protein network, selective kinase inhibition and kinome.